Insider · CIK 0001746342
Chang Carmen
Reports to the SEC for 16 companies · MENLO PARK, CA
Transactions
50
Companies
16
Filings
5
CIK
0001746342
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-11 | COURCoursera, Inc.A Award | — |
| 2026-03-10 | KRROKorro Bio, Inc. · Pre-Funded WarrantsP Purchase | +$2.7M |
| 2026-03-10 | KRROKorro Bio, Inc.P Purchase | +$2.3M |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.P Purchase | +$15M |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series A Preferred StockC Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$6,075 |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$16.6K |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$1,891.95 |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$6,075.36 |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$1,890 |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$1,861.28 |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$1,240.85 |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$16.6K |
| 2025-10-02 | NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$1,863 |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$3,722.55 |
| 2025-10-02 | NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$3,719.25 |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$1,890 |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$1,228.5 |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$1,891.95 |
| 2025-10-02 | NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-05-21 | COURCoursera, Inc.A Award | — |
| 2025-04-17 | TRVITrevi Therapeutics, Inc.X Exercise of In-Money | +$2.54M |
| 2025-04-17 | TRVITrevi Therapeutics, Inc. · 3.5-Year Common Stock WarrantX Exercise of In-Money | — |
Recent filings
- 4Chang Carmen0001193125-26-271323SEC(opens sec.gov)
- 4Chang Carmen0001193125-26-104717SEC(opens sec.gov)
- 5Chang Carmen0001193125-26-051517SEC(opens sec.gov)
- 4Chang Carmen0001193125-26-046663SEC(opens sec.gov)
- 4Chang Carmen0001193125-25-232142SEC(opens sec.gov)
Companies
- Akouos, Inc.10% Owner
- Black Diamond Therapeutics, Inc.10% OwnerBDTX
- Coursera, Inc.DirectorCOUR
- GENOCEA BIOSCIENCES, INC.10% Owner
- Korro Bio, Inc.10% OwnerKRRO
- Marker Therapeutics, Inc.10% OwnerMRKR
- MBX Biosciences, Inc.10% OwnerMBX
- Metacrine, Inc.10% Owner
- Mirum Pharmaceuticals, Inc.10% OwnerMIRM
- Monte Rosa Therapeutics, Inc.10% OwnerGLUE
- NeueHealth, Inc.Director, 10% OwnerNEUE
- Regulus Therapeutics Inc.Former 10% Owner
- Savara Inc10% OwnerSVRA
- SpyGlass Pharma, Inc.10% OwnerSGP
- Trevi Therapeutics, Inc.10% OwnerTRVI
- X4 Pharmaceuticals, Inc10% OwnerXFOR
Address
2855 SAND HILL ROAD
MENLO PARK, CA, 94025